Literature DB >> 9306412

Ribozyme therapeutics.

A Persidis1.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9306412     DOI： 10.1038/nbt0997-921

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Single bead parallel synthesis and screening.

Authors:  D Vetter; A Thamm; G Schlingloff; A Schober
Journal:  Mol Divers       Date:  2000       Impact factor: 2.943

2.  Dose-response resistance to HIV-1/MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model.

Authors:  M Andäng; J Hinkula; G Hotchkiss; S Larsson; S Britton; F Wong-Staal; B Wahren; L Ahrlund-Richter
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

3.  Preparation and identification of anti-transforming growth factor beta1 U1 small nuclear RNA chimeric ribozyme in vitro.

Authors:  Ju-Sheng Lin; Yu-Hu Song; Xin-Juan Kong; Bin Li; Nan-Zhi Liu; Xiao-Li Wu; You-Xin Jin
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.